CONCORD BIOTECH LIMITED UNIT-III

CONCORD BIOTECH LIMITED UNIT-III is a factory (manufacturer).

Company Introduction:

CONCORD BIOTECH LIMITED UNIT-III is a manufacturing facility (factory) that is part of Concord Biotech Limited, a prominent Indian biopharmaceutical company.

Concord Biotech Limited specializes in the research, development, manufacturing, and marketing of fermentation-based Active Pharmaceutical Ingredients (APIs) and finished formulations. The company is recognized as a global player in niche fermentation products, with a strong focus on therapeutic areas such as immunosuppressants, oncology, anti-fungals, and critical care.

UNIT-III represents one of Concord Biotech's dedicated production plants, underscoring its role as a manufacturing site responsible for the industrial-scale production of pharmaceutical products. The company is distinguished by its robust research and development capabilities, advanced manufacturing infrastructure, and unwavering commitment to quality standards, serving both domestic and international markets.

Therefore, CONCORD BIOTECH LIMITED UNIT-III is unequivocally a factory involved in the production of biopharmaceutical products.

Concord Biotech Limited Unit-III manufactures or sells the following products:

* Mupirocin

* Sirolimus

* Tacrolimus

* Mycophenolate mofetil

* Pimecrolimus

* Voclosporin

* Everolimus

* Clindamycin

* A variety of other fermentation and chemical synthesis-based APIs.